Extreme Obesity — The Silent Epidemic Within the Obesity Epidemic That No One Is Talking About

BMI ≥60 kg/m2 is rising faster than any other form of obesity — and remains the least studied.

What Are the Prospects for a Vaccine Against Obesity?

RNA-based and immunologic strategies are scientifically plausible — and still a long way from the clinic.

MBS Digest — Vol. 2, N.o 8 (Edición en Español)

Acceso y riesgo quirúrgico en cirugía bariátrica, evidencia comparativa de incretínicos, transparencia de la IA y un pipeline de GLP-1 en expansión.

MBS Digest Vol. 2, Issue 8: AI transparency with patients and more

This week: Bariatric access and operative risk, comparative incretin evidence, and a widening GLP-1 pipeline

We'll be at IFSO Toronto — find us, and tell us what to cover

Estaremos en el IFSO de Toronto. Búscanos — y dinos qué quieres que cubramos.

Bariatric Surgery in the Era of GLP-1 Therapy: Why Surgery Still is the Benchmark for Obesity Treatment

An editorial by Philip Schauer, MD.

MBS Digest — Vol. 2, N.o 7 (Edición en Español)

Longitud del asa en Y de Roux, nicotina tras el bypass, gobernanza de la IA y los datos de fase 3 de avexitide.

MBS Digest Vol. 2, N.o 6 — Edición en Español

Las redes sociales sustituyen al médico en la educación sobre GLP-1 — y MÁS NOTICIAS

Las últimas noticias e investigación en medicina metabólica, AQUÍ

Social Media Replaces MDs for GLP1 Ed and MORE NEWS

Get the latest news and research on Metabolic Medicine HERE

MBS Digest Vol. 2, Issue 4

Beyond BMI: A Better Lens on Obesity Risk and Bariatric Outcomes and more of the latest news in metabolic news

Heart Failure, Young Patients, and Weight Recurrence

Adolescent MBS, post-op recurrence, GLP-1 combinations, AI VTE prediction, and marketplace moves shaping obesity care.

The Future is Multidisciplinary: Is this the end of the Bariatric Technician?

MBS Training, Medicine Comparisons, Endobarriers - All in this issue of The Digest

COMMENTARY: GLP-1 Usage Hits a New High: What It Means for Bariatric Practices

New Gallup data on GLP-1 adoption, obesity trends, and the referral pattern shift bariatric practices are already seeing

Who's Really Deciding Your Patient Needs a GLP-1 First — You or the Payer?

The evidence doesn't mandate step therapy. Increasingly, the contract does.

Blade vs Needle for MACE, Endobarrier Results, and Much More

Are you keeping up with the hottest journal articles? If not, the Digest is.

Market Update

Combo Therapy for Breast Cancer and a Fountain for Youth (Maybe?)

Metabolic Surgery plus GLP-1 Adjuvant therapy becomes an attractive metabolic management protocol

This Week’s Must-Read Intelligence for Metabolic Leaders

Clinical studies on SADI, policy shifts with meds, industry movers and market watch insights in your focused digest.

Ahoy! There could be danger ahead! New Drugs and New Policy from the Latest Meetings

The MBS Digest keeps you informed of the latest news so you can avoid any rocks on the way to treasure island